Anupam Rasayan India Limited
Anupam Rasayan India Limited (ANURAS): company summary
The company's business has grown significantly, with annual revenue rising 64.6% and net profit increasing 38.8% year-over-year.
Anupam Rasayan India Limited (ANURAS) is a small-cap Chemicals company valued at ₹13,326 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Anupam Rasayan India Limited last traded at ₹1,152.4, modestly down 0.74% on the day.
- Recent developments
- On 2026-07-15, Anupam Rasayan signed a $300 mn LOI with Spain's BasqueVolt for battery chemical supply, though the agreement is preliminary and depends on product development and a definitive contract.
- Financial performance
- The company's business has grown significantly, with annual revenue rising 64.6% and net profit increasing 38.8% year-over-year. However, the net profit margin narrowed by 1.7 percentage points to 9.4%, while return on equity and return on capital employed remain low at 5.5% and 7.0%, respectively.
- Valuation multiples
- The stock trades at 76.4 times earnings, 4.25 times book value. It yields 0.1%.
- Things to watch
- The stock is 13.8% below its 52-week high, and the net profit margin has declined, which could pressure profitability. Promoter shares pledged account for 36.49% of their holding, indicating potential liquidity concerns.
- Where it stands
- Anupam Rasayan India Ltd has seen strong revenue growth, but profit growth has slowed, with margins narrowing. The company's recent LOI with BasqueVolt highlights potential expansion, but the stock remains below its recent high. The most significant figure is the 13.8% drop from the 52-week high.
Summarised by DocStoX's model on 2026-09-12 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (9.6) and risk (6.3), but held back by valuation (0.0). Growth looks strong at 9.6, but that is offset by valuation at 0.0 and momentum at 1.9. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profitable in all of the last 5 years
- Profit compounding 26% a year
- Revenue compounding 24% a year
- 22% of promoter holding is pledged
- Valuation is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore Anupam Rasayan India Limited’s valuation
Free deep-dive tools · no sign-up
Anupam Rasayan India Limited peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Anupam Rasayan India Limited with the ratios and calculators DocStoX uses in its analysis.

